Kuros Biosciences has concluded an overallotment option granted to Zürcher Kantonalbank. In total, the company raised CHF 16.9 million from the sale of 1,351,606 shares in the rights and share offering. These sale was based on the issue price of CHF 12.50 per share. The funds will be used in preparation for the commercialization of Kuros’ products in the US...